Concepedia

Koutaroh Okada

KO

Statistics

Publications

12

Citations

542

H-Index

11

Active since

1976

Affiliations

Japanese Foundation For Cancer Research(Current)

The University of Tokyo

The Cancer Institute Hospital

University of Tsukuba

Japan Society of Chemotherapy

Koutaroh Okada is an author at Japanese Foundation For Cancer Research specializing in life sciences, oncology, and pharmacology.

Publications per year

1976–2022

12

Publications

12

Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance

Koutaroh Okada, Mitsugu Araki, Takuya Sakashita et al. · EBioMedicine · 2019 · 126 citations · Full text

, , +15

Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers

Miho J. Fuse, Koutaroh Okada, Tomoko Oh‐hara et al. · Molecular Cancer Therapeutics · 2017 · 110 citations

, , +15

Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer

Hayato Mizuta, Koutaroh Okada, Mitsugu Araki et al. · Nature Communications · 2021 · 100 citations · Full text

, , +14

Visualization of modulatory effects of serotonin in the silkmoth antennal lobe

Evan S. Hill, Koutaroh Okada, Ryohei Kanzaki · Journal of Experimental Biology · 2002 · 41 citations

, , +17

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

K. Takahashi, Yosuke Seto, Koutaroh Okada et al. · Thoracic Cancer · 2020 · 36 citations · Full text

, , +14

1–5 of 12